Europe Electrophysiology Devices Market Size, Growth, Trends, Revenue and Future Outlook
Europe Electrophysiology Devices Market Growth, Size, Trends Analysis- By Product, By Disease - Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Nov-2024 | Report ID: MEDE2451 | Pages: 1 - 157 | Formats*: |
| Category : Medical Devices | |||
Europe Electrophysiology Devices Market Introduction and Overview
According to SPER Market Research, the Europe Electrophysiology Devices Market is estimated to reach USD 6.02 billion by 2033 with a CAGR 10.26%.
The report includes an in-depth analysis of the Europe Electrophysiology Devices Market, including market size and trends, product mix, distribution channels, and supplier analysis. Heart and other organ electrical irregularities are diagnosed and treated with specialist medical equipment called electrophysiology devices. These tools are mostly used in cardiology to monitor electrical activity in the heart, detect arrhythmias, and direct operations such as catheter ablation. Tools including mapping systems that visualize electrical signals, ablation devices that administer energy to eliminate aberrant tissue producing irregular heart rhythms, and electrophysiology catheters that measure electrical signals by inserting them into the heart through blood veins are commonly included. In neurology, electrophysiological devices are also used to monitor and modify brain electrical activity in order to diagnose and treat diseases such as epilepsy.
- Acutus Medical received CE Mark for its AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module (Qubic Force), and in December 2020, the AcQBlate Force Sensing Ablation System was introduced in Europe.
- Farapulse's FARAPULSE Pulsed Field Ablation (PFA) technology, which treats paroxysmal atrial fibrillation (AF), was granted the CE Mark in January 2021.
Market Opportunities and Challenges
Opportunities: The rising incidence of target diseases, developments in electrophysiology technology, and rising demand for catheter ablation operations are some of the reasons propelling the market's expansion. More than 6 million cardiovascular disease (CVD) cases were diagnosed in the European Union in 2019, and over 11 million CVD cases were reported throughout Europe annually, according to data from the European Society of Cardiology. Furthermore, each year in Europe, CVDs cause almost 3.9 million deaths. The growing incidence of cardiovascular disorders is anticipated to propel the market over the forecast period, as electrophysiological devices are widely used in the detection of heart failure rates.
Challenges: However, only a small percentage of cardiologists specialize in electrophysiology, according to the European Union of Medical Specialists. In Europe, the electrophysiological workforce is very stable, notwithstanding the unfavorable ratio. However, there is a noticeable lag in the geographical dispersion of EPs due to the lack of mobility among the bulk of established electrophysiologists. This has caused a gap between supply and demand as well as observable disparities among electrophysiologists. Therefore, a significant barrier to the expansion of the European electrophysiology business is the shortage of qualified electrophysiologists.
Market Competitive Landscape
The electrophysiology market in Europe is competitive, but not very so. A small number of the main firms presently control the majority of the market in terms of market share. Several companies have a significant market share in the European electrophysiology market, including Abbott Laboratories, Boston Scientific Corporation, Biotronik, SE and Co. KG, GE Company (GE Healthcare), Microport Scientific Corporation, and Medtronic plc.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Disease |
| Regions covered | Eastern region, Western region, Southern region, Northern region. |
| Companies Covered | Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, EP Solutions SA, GE Company (GE Healthcare), Johnson & Johnson, Koninklijke Philips N.V., Medtronic PLC, Microport Scientific Corporation, and Osypka Medical GmbH. |
COVID-19 Impact on Europe Electrophysiology Devices Market
The market for electrophysiology (EP) devices in Europe was greatly affected by the COVID-19 epidemic, both in terms of supply and demand. However, as things have improved, the market has begun to rebound. The European healthcare system had to deal with a number of issues during the pandemic's peak, such as overburdened hospital systems, postponed or cancelled non-urgent surgeries, and a change in focus to virus management. The market development temporarily slowed as a result of the postponement of elective treatments, such as those using electrophysiology equipment for diagnosing and treating arrhythmias.
Key Target Audience:
- Hospitals and Healthcare Providers
- Cardiologists and Electrophysiologists
- Medical Device Manufacturers
- Research and Academic Institutions
- Patients with Cardiac Arrhythmias
- Government and Regulatory Bodies
- Insurance Companies and Payers
Our in-depth analysis of the Europe Electrophysiology Devices Market includes the following segments:
| By Product: | |
| By Disease: |
Key Topics Covered in the Report:
- Europe Electrophysiology Devices Market Size (FY’2024-FY’2033)
- Overview of Europe Electrophysiology Devices Market
- Segmentation of Europe Electrophysiology Devices Market By Product (Ablation Catheters, Laboratery Devices, Diagnostics Catheters, Access Devices, Others)
- Segmentation of Europe Electrophysiology Devices Market By Disease (Atrial Fibrillation, Atrial Flutter, Wolff-Parkinson-White Syndrome, Atrioventricular Nodal Reentry Tachycardia, Others)
- Expansion Analysis of Europe Electrophysiology Devices Market
- Problems and Obstacles in Europe Electrophysiology Devices Market
- Competitive Landscape in the Europe Electrophysiology Devices Market
- Impact of COVID-19 and Demonetization on Europe Electrophysiology Devices Market
- Details on Current Investment in Europe Electrophysiology Devices Market
- Competitive Analysis of Europe Electrophysiology Devices Market
- Prominent Players in the Europe Electrophysiology Devices Market
- SWOT Analysis of Europe Electrophysiology Devices Market
- Europe Electrophysiology Devices Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Europe Electrophysiology Devices Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Electrophysiology Devices Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Electrophysiology Devices Market
7. Europe Electrophysiology Devices Market, By Product (USD Million) 2020-2033
7.1. Europe Electrophysiology Devices Market Size, Share and Forecast, By Product, 2020-20267.2. Europe Electrophysiology Devices Market Size, Share and Forecast, By Product, 2027-20337.3. Ablation Catheters7.4. Laboratery Devices7.5. Diagnostics Catheters7.6. Access Devices7.7. Others
8. Europe Electrophysiology Devices Market, By Disease (USD Million) 2020-2033
8.1. Europe Electrophysiology Devices Market Size, Share and Forecast, By Disease, 2020-20268.2. Europe Electrophysiology Devices Market Size, Share and Forecast, By Disease, 2027-20338.3. Atrial Fibrillation8.4. Atrial Flutter8.5. Wolff-Parkinson-White Syndrome8.6. Atrioventricular Nodal Reentry Tachycardia8.7. Others
9. Europe Electrophysiology Devices Market Forecast, 2020-2033 (USD Million)
9.1. Europe Electrophysiology Devices Market Size and Market Share
10. Europe Electrophysiology Devices Market, By Region, 2020-2033 (USD Million)
10.1. Europe Electrophysiology Devices Market Size and Market Share By Region (2020-2026)10.2. Europe Electrophysiology Devices Market Size and Market Share By Region (2027-2033)10.3. France10.4. Germany10.5. Italy10.6. Spain10.7. United Kingdom10.8. Rest of Europe
11. Company Profile
11.1. Abbott Laboratories11.1.1. Company details11.1.2. Financial outlook11.1.3. Product summary11.1.4. Recent developments11.2. Biotronik SE & Co. KG11.2.1. Company details11.2.2. Financial outlook11.2.3. Product summary11.2.4. Recent developments11.3. Boston Scientific Corporation11.3.1. Company details11.3.2. Financial outlook11.3.3. Product summary11.3.4. Recent developments11.4. EP Solutions SA11.4.1. Company details11.4.2. Financial outlook11.4.3. Product summary11.4.4. Recent developments11.5. GE Company (GE Healthcare)11.5.1. Company details11.5.2. Financial outlook11.5.3. Product summary11.5.4. Recent developments11.6. Johnson & Johnson11.6.1. Company details11.6.2. Financial outlook11.6.3. Product summary11.6.4. Recent developments11.7. Koninklijke Philips N.V.11.7.1. Company details11.7.2. Financial outlook11.7.3. Product summary11.7.4. Recent developments11.8. Medtronic PLC11.8.1. Company details11.8.2. Financial outlook11.8.3. Product summary11.8.4. Recent developments11.9. Microport Scientific Corporation11.9.1. Company details11.9.2. Financial outlook11.9.3. Product summary11.9.4. Recent developments11.10. Osypka Medical GmbH11.10.1. Company details11.10.2. Financial outlook11.10.3. Product summary11.10.4. Recent developments11.11. Others
12. Conclusion
13. Reference Links
14. List of Abbreviations
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Electrophysiology Devices Market grew in Market size from 2024. The Market is expected to reach USD 6.02 billion by 2033, at a CAGR of 10.26% during the forecast period.
Europe Electrophysiology Devices Market CAGR of 10.26% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Electrophysiology Devices Market size is USD 6.02 billion from 2024 to 2033.
Europe Electrophysiology Devices Market is covered By Product, By Disease
The Europe is anticipated to have the highest Market share in the Europe Electrophysiology Devices Market.
The Key players in the Market include Companies Covered Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, EP Solutions SA, GE Company (GE Healthcare), Johnson & Johnson, Koninklijke Philips N.V., Medtronic PLC, Microport Scientific Corporation, and Osypka Medical GmbH.
The high cost of advanced diabetes drugs and the financial burden of treating diabetes remain major obstacles to market growth, despite the fact that numerous drugs have been approved for the condition and that governments and industry players are launching numerous initiatives.
Europe Electrophysiology Devices Market is projected to reach USD 6.02 billion by 2033, growing at a CAGR of 10.26% during the forecast period.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
